Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mach5 Therapeutics

Request full access

Biotechnology firm advancing therapeutics for immune-mediated inflammatory and fibrotic diseases

Atlanta, United StatesFounded 2023Biotech & Life Sciences

About Mach5 Therapeutics

Mach5 Therapeutics is a privately held biotechnology company focused on developing advanced therapeutics for immune-mediated inflammatory and fibrotic diseases. Founded by experienced drug developers from ValenzaBio and AlmataBio, the company aims to transform patient care through its innovative approach to medicine. Operating in the biotechnology sector, Mach5 Therapeutics targets healthcare providers and patients affected by these complex conditions. The business model revolves around research and development, with revenue generated through partnerships, licensing agreements, and potential commercialization of successful therapies. The company's strategic focus is on leveraging its expertise to address unmet medical needs in the field of immunology and fibrosis.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
Atlanta, United States
Employees
1
Open positions
None listed
Dealroom signal
56.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Woman Founder, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Nov 2024 $19M $77M Undisclosed ↗
SEED✓Equity / VC Mar 2024 $4.2M $17M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Mach5 Therapeutics website traffic

Latest recorded traffic for Mach5 Therapeutics is 1.5K monthly website visits, up 70.5% over the last three months. Mach5 Therapeutics's team declined 50% over the past year.

Latest monthly visits1.5K 3-month web change+70.5% 1-year team growth-50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Mach5 Therapeutics in the Atlanta ecosystem

Live from Dealroom

The Mach5 Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Atlanta HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mach5 Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mach5 Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.